JP2003212751A - Gel composition and oil-in-water (o/w) composition - Google Patents
Gel composition and oil-in-water (o/w) compositionInfo
- Publication number
- JP2003212751A JP2003212751A JP2002013762A JP2002013762A JP2003212751A JP 2003212751 A JP2003212751 A JP 2003212751A JP 2002013762 A JP2002013762 A JP 2002013762A JP 2002013762 A JP2002013762 A JP 2002013762A JP 2003212751 A JP2003212751 A JP 2003212751A
- Authority
- JP
- Japan
- Prior art keywords
- oil
- composition
- gel
- general formula
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 24
- 150000001875 compounds Chemical class 0.000 claims abstract description 25
- 150000003839 salts Chemical class 0.000 claims abstract description 11
- 239000001257 hydrogen Substances 0.000 claims abstract description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 6
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims abstract description 6
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims abstract description 5
- 125000002252 acyl group Chemical group 0.000 claims abstract description 5
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 5
- 150000001340 alkali metals Chemical class 0.000 claims abstract description 5
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims abstract description 5
- 150000001342 alkaline earth metals Chemical class 0.000 claims abstract description 5
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 37
- 235000011187 glycerol Nutrition 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 8
- VZWXIQHBIQLMPN-UHFFFAOYSA-N chromane Chemical group C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 239000006071 cream Substances 0.000 abstract description 3
- 230000003405 preventing effect Effects 0.000 abstract description 2
- 238000007788 roughening Methods 0.000 abstract description 2
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 230000001550 time effect Effects 0.000 abstract 1
- 239000000499 gel Substances 0.000 description 25
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 239000003921 oil Substances 0.000 description 12
- -1 lipid peroxides Chemical class 0.000 description 10
- 239000006210 lotion Substances 0.000 description 10
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 230000007794 irritation Effects 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 230000001804 emulsifying effect Effects 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000004945 emulsification Methods 0.000 description 4
- 230000001766 physiological effect Effects 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000003779 hair growth Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- TUYRNAGGIJZRNM-LBHUVFDKSA-N [(2s)-2-[(2r)-4-hexadecanoyloxy-3-hydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethyl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(OC(=O)CCCCCCCCCCCCCCC)=C1O TUYRNAGGIJZRNM-LBHUVFDKSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 231100000245 skin permeability Toxicity 0.000 description 1
- ODFAPIRLUPAQCQ-UHFFFAOYSA-M sodium stearoyl lactylate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O ODFAPIRLUPAQCQ-UHFFFAOYSA-M 0.000 description 1
- 229940080352 sodium stearoyl lactylate Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、一般式1に示され
る化合物および/またはその塩を含有することを特徴と
するゲル組成物および水中油(O/W)型組成物に関す
るものである。より詳しくは、一般式1に示される化合
物および/またはその塩を含有することにより、油を含
んだゲル組成物を形成させることが可能で、更にはこの
ゲル組成物を水で希釈することにより均一で安定な乳化
組成物を得ることができることに関する。また、配合す
る油の種類や量を調整することにより、ミセル、ベシク
ル、エマルションといった様々な水中油(O/W)型組
成物を目的に応じて調製することができる。TECHNICAL FIELD The present invention relates to a gel composition and an oil-in-water (O / W) type composition characterized by containing a compound represented by the general formula 1 and / or a salt thereof. More specifically, by containing the compound represented by the general formula 1 and / or a salt thereof, it is possible to form an oil-containing gel composition, and further by diluting the gel composition with water. It relates to being able to obtain a homogeneous and stable emulsion composition. In addition, various oil-in-water (O / W) compositions such as micelles, vesicles and emulsions can be prepared according to the purpose by adjusting the type and amount of oil to be blended.
【0002】[0002]
【従来の技術】近年、人的な安全性の面で製剤において
乳化剤として使用する界面活性物質の配合量を減らした
り、より作用の温和なものを使用する研究がなされてき
た。その様な中で、有益な生理活性を持つ物質、いわゆ
る有効成分に乳化剤の役割までも担わせる研究がなされ
てきた。2. Description of the Related Art In recent years, from the viewpoint of human safety, studies have been made to reduce the amount of the surface-active substance used as an emulsifier in a preparation or to use a milder one. Under such circumstances, studies have been conducted to make substances having beneficial physiological activity, so-called active ingredients, even play a role of emulsifiers.
【0003】またヒトに対し外用する製剤に関しては、
経時安定性に優れており、更には皮膚に対する刺激が低
く安全性の高いことはもちろん、有効成分の経皮吸収
性、皮膚細胞内富化性をはじめとする有効成分の体内動
態の向上が求められてきた。Further, regarding a preparation to be applied externally to humans,
In addition to excellent stability over time, low irritation to the skin and high safety, it is also required to improve percutaneous absorption of the active ingredient and improvement in the pharmacokinetics of the active ingredient, including skin intracellular enrichment. Has been.
【0004】[0004]
【発明が解決しようとする課題】この様な状況の中で、
化粧品等の皮膚外用剤に求められるのは有益な生理活性
を持つ成分自身でゲル組成物を形成し得ること、さらに
はそのゲル組成物に水を加えることにより物理的に弱い
攪拌力で効率よく経時的に安定である微細な乳化粒子を
形成させること、同時に皮膚に対する刺激性が低いこと
である。[Problems to be Solved by the Invention] In such a situation,
What is required of external preparations for skin such as cosmetics is that a gel composition can be formed by a component having a beneficial physiological activity, and further, by adding water to the gel composition, it is possible to efficiently use a physically weak stirring force. The formation of fine emulsified particles that are stable over time, and at the same time, low irritation to the skin.
【0005】[0005]
【課題を解決するための手段】本発明者等は、かかる実
情に鑑み鋭意検討した結果、一般式1に示される化合物
および/またはその塩を含有することにより、自己組織
体形成能が高く、経時安定性に優れており、更には油の
乳化能が高く、皮膚に対する刺激が低く安全性の高い、
ゲル組成物および水中油(O/W)型組成物の発明を完
成するに至った。Means for Solving the Problems The inventors of the present invention have made extensive studies in view of such circumstances, and as a result, by containing the compound represented by the general formula 1 and / or a salt thereof, the self-organizing ability is high, Excellent stability over time, high oil emulsifying ability, low irritation to the skin and high safety,
The invention of a gel composition and an oil-in-water (O / W) type composition was completed.
【0006】すなわち、本発明のゲル組成物および乳化
組成物は、一般式1に示される化合物および/またはそ
の塩を含有するものであり、自己組織体形成能が高く、
経時安定性に優れており、更には油の乳化能が高く、皮
膚に対する刺激が低く安全性の高い組成物である。That is, the gel composition and the emulsified composition of the present invention contain the compound represented by the general formula 1 and / or a salt thereof and have high self-organizing ability.
The composition is excellent in stability over time, has a high oil emulsifying ability, has low irritation to the skin, and is highly safe.
【0007】以下、本発明の構成について詳述する。The structure of the present invention will be described in detail below.
【0008】本発明で用いられる一般式1の物質はクロ
マン骨格を持ち、肌あれに対し非常に有効な防御効果を
持つ化合物である。これらの化合物は抗酸化能力に優
れ、生体内における活性酸素、それに由来する過酸化脂
質やフリーラジカルの弊害を予防したり、血行促進を代
表とする生理活性作用により育毛・発毛効果を発揮した
り、例えばビタミンやその誘導体と共存することにより
相乗効果的にお互いの有効性を向上させることができ
る。The substance represented by the general formula 1 used in the present invention is a compound having a chroman skeleton and having a very effective protective effect against rough skin. These compounds have excellent antioxidant ability, prevent the harmful effects of active oxygen in the body, lipid peroxides and free radicals derived from them, and exert a hair growth and hair growth effect by a physiologically active action represented by blood circulation promotion. Or, for example, coexistence with vitamins and their derivatives can synergistically improve each other's effectiveness.
【0009】具体的にはR1、R2はそれぞれ水素、ア
ルキル基、アシル基、酸化エチレン、アルカリ金属、ア
ルカリ土類金属等のひとつ以上から選ばれ、必要に応じ
て組み合わせてもよい。これらの選択により溶解性、ゲ
ル形成性、自己会合性等の物性を変化させることができ
る。Specifically, each of R 1 and R 2 is selected from one or more of hydrogen, an alkyl group, an acyl group, ethylene oxide, an alkali metal, an alkaline earth metal and the like, and may be combined if necessary. Physical properties such as solubility, gel-forming property and self-association property can be changed by these selections.
【0010】本発明で用いられる一般式1に示される化
合物は、好ましくは、R1、R2の少なくともひとつが
ナトリウムである。さらに含有量は、特に限定されるも
のではないが0.1〜25重量%とすることが好まし
く、0.1重量%未満では生理活性、ゲル形成能、乳化
能に劣り安定なゲル組成物および水中油(O/W)型組
成物が得られない場合があり、25重量%を超えて含有
することは可能であるがゲル組成物および乳化組成物と
して経済的でない。In the compound represented by the general formula 1 used in the present invention, at least one of R 1 and R 2 is preferably sodium. Further, the content is not particularly limited, but is preferably 0.1 to 25% by weight, and if less than 0.1% by weight, a stable gel composition having poor physiological activity, gel forming ability and emulsifying ability and An oil-in-water (O / W) type composition may not be obtained in some cases, and the content of more than 25% by weight is possible, but it is not economical as a gel composition and an emulsion composition.
【0011】また、本発明におけるグリセリンの役割は
非常に大きいものがある。一般式1に示される化合物は
単独でもゲルを形成したり水中油(O/W)型組成物を
形成したりする能力を有するが、グリセリンを添加する
ことによりその分散性が向上し、この化合物の持ち得る
能力を存分に発揮させることが可能となる。その配合量
は特に限定されないが、0.5〜60%が好ましく、
0.5%未満では顕著な効果が認められない場合があ
り、60%を超えて配合することは可能であるが使用感
触の面でべとつきを感じ、デメリットとなる場合があ
る。Further, the role of glycerin in the present invention is very important. The compound represented by the general formula 1 has the ability to form a gel or an oil-in-water (O / W) type composition alone, but the addition of glycerin improves its dispersibility. It will be possible to fully utilize the potential of the. The blending amount is not particularly limited, but is preferably 0.5 to 60%,
If it is less than 0.5%, a remarkable effect may not be recognized in some cases, and if it exceeds 60%, it may be blended, but it may be disadvantageous because it feels sticky in use.
【0012】ゲルの調製においては特に限定されない
が、一般式1をグリセリンと良く混合し、この状態に油
を少しずつ撹拌しながら添加していくことによりゲルを
形成する方法が好ましい。この他の方法においてもゲル
を形成することは可能であるが、高温での処理が必要で
あったり、機械的な撹拌シェアを必要としたりするた
め、前述の方法を用いることで手軽に安全にゲルを製造
することが可能となる。The preparation of the gel is not particularly limited, but a method of forming a gel by thoroughly mixing General Formula 1 with glycerin and adding oil to this state while stirring little by little is preferable. It is possible to form a gel by other methods as well, but since it requires treatment at high temperature or mechanical shearing share, it is easy and safe to use the above method. It becomes possible to produce a gel.
【0013】本発明の組成物は上記必須成分の他に、通
常の皮膚外用剤に用いられる化粧料、医薬部外品、医薬
品等の各種成分、さらに食品に用いられる成分を配合す
ることができる。例えば油性成分、脂質、保湿剤、増粘
剤、薬効成分、殺菌・防腐剤、顔料、粉体、pH調整
剤、紫外線吸収剤、抗酸化剤、可塑剤、香料、アミノ
酸、甘味料、着色料等を適宜配合することができる。さ
らにゲル形成能や乳化能を補助する役割で他の界面活性
剤も配合することができる。In addition to the above-mentioned essential components, the composition of the present invention may contain various components such as cosmetics, quasi drugs, pharmaceuticals and the like which are commonly used in external preparations for skin, and components which are used in foods. . For example, oily ingredients, lipids, humectants, thickeners, medicinal ingredients, bactericidal / preservatives, pigments, powders, pH adjusters, UV absorbers, antioxidants, plasticizers, fragrances, amino acids, sweeteners, colorants. Etc. can be blended appropriately. Further, other surfactants can be blended in the role of assisting gel forming ability and emulsifying ability.
【0014】具体的には油性成分としては、例えば炭化
水素、植物由来油、昆虫由来油、動物油脂、トリグリセ
ライド、高級アルコール、脂肪酸、高級アルコールと脂
肪酸のエステル、シリコーン油等が挙げられる。保湿剤
としては、例えば多価アルコール、高分子多糖類、植物
抽出エキス、微生物の代謝物などが挙げられる。増粘剤
としては、例えばカルボキシビニルポリマー、キサンタ
ンガム、メチルセルロース、ポリビニルピロリドン、ゼ
ラチン、ベントナイト等の粘土鉱物等が挙げられる。薬
効成分としては、例えば各種ビタミンおよびその誘導
体、アラントイン、グリチルリチン酸およびその誘導
体、各種動植物抽出物等が挙げられる。さらに乳化剤と
しては、例えばポリオキシエチレンアルキルエーテル、
ポリオキシエチレン脂肪酸エステル、ポリオキシエチレ
ンソルビタン脂肪酸エステル、ソルビタン脂肪酸エステ
ル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸
エステル、ポリオキシエチレン硬化ヒマシ油等の非イオ
ン界面活性剤、ステアロイル乳酸ナトリウム等のアニオ
ン界面活性剤、リン脂質等の両性界面活性剤、塩化アル
キルトリメチルアンモニウム等のカチオン界面活性剤が
挙げられる。Specific examples of the oily component include hydrocarbons, plant-derived oils, insect-derived oils, animal fats and oils, triglycerides, higher alcohols, fatty acids, esters of higher alcohols and fatty acids, silicone oils and the like. Examples of the moisturizer include polyhydric alcohols, high molecular polysaccharides, plant extracts, and metabolites of microorganisms. Examples of the thickener include carboxyvinyl polymers, xanthan gum, methylcellulose, polyvinylpyrrolidone, gelatin, clay minerals such as bentonite, and the like. Examples of the medicinal component include various vitamins and their derivatives, allantoin, glycyrrhizic acid and its derivatives, various animal and plant extracts, and the like. Further, as the emulsifier, for example, polyoxyethylene alkyl ether,
Polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, sorbitan fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, nonionic surfactant such as polyoxyethylene hydrogenated castor oil, anionic surfactant such as sodium stearoyl lactylate, Examples thereof include amphoteric surfactants such as phospholipids and cationic surfactants such as alkyltrimethylammonium chloride.
【0015】本発明のゲル組成物および水中油(O/
W)型組成物は公知の方法により製造することができ、
化粧料、医薬部外品、外用医薬品、食品等の分野を問わ
ず利用できるものであり、その剤型は目的に応じて任意
に選択でき、クリーム、乳液、ローション、ゲル、軟
膏、パック、スティック等の形態とすることができる。The gel composition of the present invention and oil-in-water (O /
The W) type composition can be produced by a known method,
It can be used regardless of the fields of cosmetics, quasi drugs, external medicines, foods, etc., and its dosage form can be arbitrarily selected according to the purpose, and creams, emulsions, lotions, gels, ointments, packs, sticks can be used. And the like.
【0016】[0016]
【発明の効果】本発明のゲル組成物および水中油(O/
W)型組成物は、一般式1に示される化合物および/ま
たはその塩を含有するものであり、従来から一般的に用
いられている界面活性物質に比べ、有益な生理活性を有
しながら、ゲル化能や油の保持能に優れ、配合成分を調
整することによりミセル、ベシクル、乳化粒子を形成
し、経時安定性に優れており、更には皮膚に対する刺激
が低く、経皮吸収性が高いため皮膚の細胞内に富化する
ことのできる安全性に優れたものである。The gel composition of the present invention and the oil-in-water (O /
The W) type composition contains a compound represented by the general formula 1 and / or a salt thereof, and has a beneficial physiological activity as compared with a conventionally generally used surfactant. It has excellent gelling ability and oil retaining ability, and it forms micelles, vesicles, and emulsified particles by adjusting the compounding ingredients, and it has excellent stability over time. Furthermore, it has low irritation to the skin and high transdermal absorbability. Therefore, it is highly safe and can be enriched in the cells of the skin.
【0017】これらの効果を実証するために実施例1〜
16を調製し評価した。In order to demonstrate these effects, Examples 1 to 1
16 was prepared and evaluated.
【0018】実施例に先立ち、本発明で用いたゲル化方
法、乳化方法を説明する。Prior to the examples, the gelation method and the emulsification method used in the present invention will be described.
【0019】(ゲル化方法)以下の処方にて、一般式1
に示される化合物とグリセリン(A部)を常温にて充分
攪拌した後、60℃に加温、同じく60℃に加温した油
相(B部)をA部に攪拌しながら徐々に加える。その後
室温まで冷却してゲル組成物を得た。(Gelification method) The following formula was used to formula 1
After thoroughly stirring the compound shown in (1) and glycerin (part A) at room temperature, the oil phase (part B) which was heated to 60 ° C. and also heated to 60 ° C. was gradually added to part A while stirring. Then, it cooled to room temperature and obtained the gel composition.
【0020】A 一般式1に示される化合物 グリセリン B トリオクタン酸グリセリルA compound represented by the general formula 1 Glycerin B Glyceryl trioctanoate
【0021】[結果]表1に示すとおり、一般式1に示
される化合物は良好なゲル形成能を有することが示され
た。また、このゲル形成能はグリセリンの配合で、より
向上することが示された。[Results] As shown in Table 1, the compound represented by the general formula 1 was shown to have a good gel-forming ability. It was also shown that this gel-forming ability was further improved by the addition of glycerin.
【0022】[0022]
【表1】 [Table 1]
【0023】(乳化方法)以下の処方にて、一般式1に
示される化合物とグリセリンの適量(A部)を常温にて
充分攪拌した後、60℃に加温、同じく60℃に加温し
た油相(B部)をA部に攪拌しながら徐々に加える。そ
の後70℃に加温した水相(C部)を加え、グリセリン
の残りを加え撹拌しながら室温まで冷却し水中油(O/
W)型乳化組成物を得た。(Emulsification Method) In the following formulation, the compound represented by the general formula 1 and an appropriate amount of glycerin (part A) were thoroughly stirred at room temperature, and then heated to 60 ° C. and also to 60 ° C. The oil phase (part B) is gradually added to part A with stirring. Thereafter, an aqueous phase (part C) heated to 70 ° C. was added, the rest of glycerin was added, and the mixture was cooled to room temperature with stirring and oil-in-water (O /
A W) type emulsion composition was obtained.
【0024】A 一般式1に示される化合物 グリセリン B ジカプリン酸ネオペンチルグリコール C プロピレングリコール 防腐剤 精製水A compound represented by the general formula 1 Glycerin B Neopentyl glycol dicaprate C Propylene glycol Preservative purified water
【0025】[結果]表2に示すとおり、一般式1に示
される化合物は良好な水中油(O/W)型組成物形成能
を有することが示された。また、このゲル形成能はグリ
セリンの配合で、より向上することが示された。[Results] As shown in Table 2, it was shown that the compound represented by the general formula 1 had a good oil-in-water (O / W) type composition forming ability. It was also shown that this gel-forming ability was further improved by the addition of glycerin.
【0026】[0026]
【表2】 [Table 2]
【0027】以上説明したように、本発明によれば、一
般式1に示される化合物および/またはその塩を含有す
ることにより、油の乳化能が高く、経時安定性に優れた
ゲル組成物および水中油(O/W)型組成物を提供する
ことが可能となる。更に、グリセリンを添加することで
より良好な組成物が得られることが見出された。As described above, according to the present invention, by containing the compound represented by the general formula 1 and / or a salt thereof, a gel composition having a high oil emulsifying ability and excellent stability over time and It becomes possible to provide an oil-in-water (O / W) type composition. Furthermore, it has been found that a better composition can be obtained by adding glycerin.
【0028】[0028]
【実施例】以下に本発明を、詳細に説明するため実施例
を挙げるが、本発明はこれらに限定されるものではな
い。EXAMPLES The present invention will now be described with reference to examples, but the present invention is not limited thereto.
【0029】 実施例13 保湿ゲルクリーム A 一般式1に示される化合物(R1、R2ともナトリウム) 2.0重量% グリセリン 5.0 B スクワラン 40.0 ミリスチン酸オクチルドデシル 59.5 ステアリルアルコール 2.0 セタノール 1.0 アスコルビン酸ジパルミテート 適量 香料 適量Example 13 Moisturizing Gel Cream A Compound represented by General Formula 1 (sodium for R 1 and R 2 ) 2.0% by weight Glycerin 5.0 B Squalane 40.0 Octyldodecyl myristate 59.5 Stearyl alcohol 2 0.0 Cetanol 1.0 Ascorbic acid dipalmitate Suitable amount Perfume Suitable amount
【0030】よく混合したA部に完全に均一に溶解した
B部を攪拌しながら徐々に加えてゲル組成物を得る。得
られたゲル組成物は経時安定性に優れており、皮膚に対
する刺激が低く、良好な保湿ゲルクリームであった。A gel composition is obtained by gradually adding, with stirring, Part B, which is completely and uniformly dissolved, to Part A that has been well mixed. The obtained gel composition was excellent in stability over time, had low irritation to the skin, and was a good moisturizing gel cream.
【0031】 実施例14 ローション1 A 一般式1に示される化合物 (R1、R2の何れかがナトリウム、他方は水素) 2.0重量% B グリセリン 30.0 C プロピレングリコール 5.0 アスコルビン酸グルコシド 0.5 水素添加レシチン 1.0 ペンチレングリコール 5.0 香料 適量 D 水酸化ナトリウム pH調整 精製水 残余Example 14 Lotion 1 A Compound represented by the general formula 1 (either R 1 or R 2 is sodium, the other is hydrogen) 2.0% by weight B glycerin 30.0 C propylene glycol 5.0 ascorbic acid Glucoside 0.5 Hydrogenated lecithin 1.0 Pentylene glycol 5.0 Fragrance D Sodium hydroxide pH adjustment Purified water Residual
【0032】A部をB部に溶解する。C部にはD部の一
部を加え均一に溶解する。それぞれ均一に溶解した後混
合し、D部にて全量100%に調整する。得られたロー
ションは粒子径数十〜数μmの微細なベシクルを含有す
るややにごった水中油(O/W)型懸濁ローションで、
経時安定性、皮膚への浸透性に優れ、肌あれを良く防い
だ。Part A is dissolved in part B. Add part of part D to part C and dissolve uniformly. After they are uniformly dissolved, they are mixed and the total amount is adjusted to 100% in part D. The obtained lotion is a slightly turbid oil-in-water (O / W) type suspension lotion containing fine vesicles having a particle size of several tens to several μm.
It has excellent stability over time and penetration into the skin, and prevents skin roughening.
【0033】 実施例15 ローション2 A 一般式1に示される化合物(R1、R2の何れもナトリウム) 2.0重量% B プロピレングリコール 5.0 C パルミチン酸レチノール 0.1 防腐剤 適量 香料 適量 D 精製水 残余Example 15 Lotion 2 A Compound represented by the general formula 1 (both R 1 and R 2 are sodium) 2.0% by weight B propylene glycol 5.0 C retinol palmitate 0.1 preservative proper amount perfume proper amount D Purified water Residual
【0034】A部をB部に溶解後均一に混和したC部を
加え、最後にD部を加える。混合した液を超高圧ジェッ
ト流反転型乳化装置(商品名:DeBee2000)で
処理する。得られたローションは粒子径が0.1〜数十
μmの微細なベシクルを含有した、ややにごった水中油
(O/W)型懸濁ローションで、経時安定性、皮膚への
浸透性に優れ、肌あれを良く防いだ。After dissolving part A in part B, part C which has been uniformly mixed is added, and finally part D is added. The mixed liquid is treated with an ultra-high pressure jet flow inversion type emulsification device (trade name: DeBee2000). The obtained lotion is a slightly turbid oil-in-water (O / W) type suspension lotion containing fine vesicles having a particle size of 0.1 to several tens of μm, and has excellent stability over time and skin permeability. , Well prevented the skin.
【0035】 実施例16 ローション3 A 一般式1に示される化合物(R1、R2の何れもナトリウム) 2.0重量% B グリセリン 10.0 C プロピレングリコール 5.0 パルミチン酸レチノール 0.1 防腐剤 適量 香料 適量 D 精製水 残余Example 16 Lotion 3 A Compound represented by General Formula 1 (both R 1 and R 2 are sodium) 2.0 wt% B glycerin 10.0 C propylene glycol 5.0 retinol palmitate 0.1 preservative Agent Suitable amount Perfume Suitable amount D Purified water Residual
【0036】A部をB部に溶解後均一に混和したC部を
加え、最後にD部を加える。混合した液を超高圧ジェッ
ト流反転型乳化装置(商品名:DeBee2000)で
実施例15と同条件で処理する。得られたローションは
粒子径数十nmといった、実施例15で得られたものよ
り微細なベシクルを含有し、わずかににごった水中油
(O/W)型懸濁ローションで、皮膚への浸透性に優
れ、肌あれを良く防いだ。ただし、経時安定性について
は実施例15より優れ、グリセリンを配合するメリット
が示された。After dissolving the A part in the B part, the uniformly mixed C part is added, and finally the D part is added. The mixed liquid is treated under the same conditions as in Example 15 in an ultrahigh pressure jet flow inversion type emulsification device (trade name: DeBee2000). The obtained lotion contains finer vesicles than the particle size obtained in Example 15, such as a particle size of several tens nm, and is a slightly turbid oil-in-water (O / W) type suspension lotion, which has a permeability to the skin. Excellent in preventing the skin from getting rough. However, the stability over time was superior to that of Example 15, showing the merit of incorporating glycerin.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 北原 路郎 愛知県名古屋市西区鳥見町2−7 日本メ ナード化粧品株式会社総合研究所 (72)発明者 中田 悟 愛知県名古屋市西区鳥見町2−7 日本メ ナード化粧品株式会社総合研究所 Fターム(参考) 4C083 AB032 AB051 AB052 AC022 AC072 AC121 AC122 AC352 AC901 AC902 AD572 AD622 AD642 CC05 DD33 DD41 EE01 EE10 EE12 EE22 FF05 ─────────────────────────────────────────────────── ─── Continued front page (72) Inventor Jiro Kitahara 2-7 Torimicho, Nishi-ku, Nagoya-shi, Aichi Japan Nard Cosmetics Co., Ltd. (72) Inventor Satoru Nakata 2-7 Torimicho, Nishi-ku, Nagoya-shi, Aichi Japan Nard Cosmetics Co., Ltd. F-term (reference) 4C083 AB032 AB051 AB052 AC022 AC072 AC121 AC122 AC352 AC901 AC902 AD572 AD622 AD642 CC05 DD33 DD41 EE01 EE10 EE12 EE22 FF05
Claims (7)
ルキル基、アシル基、酸化エチレン、アルカリ金属、ア
ルカリ土類金属等からひとつ以上選ばれる)に示される
クロマン骨格を含む化合物および/またはその塩を含有
することを特徴とするゲル組成物。 【化1】 1. A compound containing a chroman skeleton represented by the general formula 1 (R 1 and R 2 are each selected from hydrogen, an alkyl group, an acyl group, ethylene oxide, an alkali metal, an alkaline earth metal and the like) and And / or a salt thereof. [Chemical 1]
ことを特徴とする請求項1に記載のゲル組成物。2. The gel composition according to claim 1, which contains 0.5 to 60% by weight of glycerin.
ルキル基、アシル基、酸化エチレン、アルカリ金属、ア
ルカリ土類金属等からひとつ以上選ばれる)に示される
クロマン骨格を含む化合物および/またはその塩とグリ
セリンを混合し、その後撹拌しながら油を添加する方法
にて調製される請求項2に記載のゲル組成物。3. A compound containing a chroman skeleton represented by the general formula 1 (R 1 and R 2 are each selected from hydrogen, an alkyl group, an acyl group, ethylene oxide, an alkali metal, an alkaline earth metal and the like) and The gel composition according to claim 2, which is prepared by a method of mixing // its salt and glycerin, and then adding oil with stirring.
に、水を添加して乳化した乳化組成物。4. An emulsified composition obtained by adding water to the gel composition according to claim 1 to emulsify it.
ルキル基、アシル基、酸化エチレン、アルカリ金属、ア
ルカリ土類金属等からひとつ以上選ばれる)に示される
クロマン骨格を含む化合物および/またはその塩を含有
することを特徴とする水中油(O/W)型組成物。5. A compound containing a chroman skeleton represented by the general formula 1 (R 1 and R 2 are each selected from hydrogen, an alkyl group, an acyl group, ethylene oxide, an alkali metal, an alkaline earth metal and the like) and And / or an oil-in-water (O / W) type composition containing a salt thereof.
ことを特徴とする請求項4に記載の水中油(O/W)型
組成物。6. The oil-in-water (O / W) type composition according to claim 4, wherein glycerin is added in an amount of 0.5 to 60% by weight.
その塩の配合量が0.1〜25重量%であることを特徴
とする請求項1乃至請求項5に記載の組成物。7. The composition according to claim 1, wherein the compound of the general formula 1 and / or its salt is compounded in an amount of 0.1 to 25% by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002013762A JP3712673B2 (en) | 2002-01-23 | 2002-01-23 | Gel composition and oil-in-water (O / W) type composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002013762A JP3712673B2 (en) | 2002-01-23 | 2002-01-23 | Gel composition and oil-in-water (O / W) type composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003212751A true JP2003212751A (en) | 2003-07-30 |
| JP3712673B2 JP3712673B2 (en) | 2005-11-02 |
Family
ID=27650636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002013762A Expired - Lifetime JP3712673B2 (en) | 2002-01-23 | 2002-01-23 | Gel composition and oil-in-water (O / W) type composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3712673B2 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006008620A (en) * | 2004-06-28 | 2006-01-12 | Fancl Corp | Emulsion composition containing oil-soluble ascorbic acid derivative |
| JP2013091619A (en) * | 2011-10-26 | 2013-05-16 | Fancl Corp | Cosmetic |
| JP2014169251A (en) * | 2013-03-04 | 2014-09-18 | Fancl Corp | Emulsion composition |
| JP2014189550A (en) * | 2013-03-28 | 2014-10-06 | Fancl Corp | Oily composition |
-
2002
- 2002-01-23 JP JP2002013762A patent/JP3712673B2/en not_active Expired - Lifetime
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006008620A (en) * | 2004-06-28 | 2006-01-12 | Fancl Corp | Emulsion composition containing oil-soluble ascorbic acid derivative |
| JP2013091619A (en) * | 2011-10-26 | 2013-05-16 | Fancl Corp | Cosmetic |
| JP2014169251A (en) * | 2013-03-04 | 2014-09-18 | Fancl Corp | Emulsion composition |
| JP2014189550A (en) * | 2013-03-28 | 2014-10-06 | Fancl Corp | Oily composition |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3712673B2 (en) | 2005-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4764588B2 (en) | Gelled aqueous cosmetic composition | |
| JP5432470B2 (en) | Ceramide solution and external preparation for skin | |
| CN102665650A (en) | Cosmetic composition stabilized higher oily part | |
| EP1513492A1 (en) | Microemulsions having a binary phase differentiability and active substance differentiability, the production thereof and their use, particularly for the topical supply of oxygen | |
| CN104135994A (en) | Lycopene-containing composition | |
| JP2000229832A (en) | Skin lotion | |
| JP6753312B2 (en) | Topical skin preparation for medical use | |
| KR100638602B1 (en) | Cosmetics in Water-in-oil Multi-emulsion Using Polyprotose-based Polymer Emulsifiers Modified with Lipophilic Type and Manufacturing Method Thereof | |
| TW200916118A (en) | External preparation for skin | |
| JP2005179313A (en) | Method for producing base agent for skin cosmetic, and skin cosmetic | |
| JP2004002289A (en) | Parakeratosis inhibitor | |
| KR101761005B1 (en) | Cosmetic composition containing non-toxic sulfur for sikn moisture, anti-inflammatory and immune enhancement and manufacturing the same | |
| JP2025085824A (en) | Composition for external use containing azelaic acid and its manufacturing method | |
| JP4594661B2 (en) | Emulsified composition containing oil-soluble ascorbic acid derivative | |
| JP6450144B2 (en) | Liposomes and liposome-containing cosmetics | |
| JP3799276B2 (en) | Gel composition and emulsion composition | |
| JP3712673B2 (en) | Gel composition and oil-in-water (O / W) type composition | |
| JP2001163766A (en) | Compositions containing pentacyclic triterpene acids, especially cosmetic compositions | |
| JP2024114984A (en) | Emulsion composition | |
| JP3740069B2 (en) | Topical skin preparation | |
| JP5338030B2 (en) | Adapalene-containing external preparation composition | |
| JP2004346039A (en) | Emulsified composition | |
| JP2006306793A (en) | Emulsified cosmetic | |
| JP5670008B2 (en) | Adapalene-containing external preparation composition | |
| JP5109382B2 (en) | Adapalene-containing external preparation composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20041117 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20041203 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20050527 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050607 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050711 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20050809 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20050817 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 3712673 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110826 Year of fee payment: 6 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140826 Year of fee payment: 9 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |